Reduced risk of second primary cancer in patients treated with immune checkpoint inhibitors for a first cancer
Author:
Funder
European Commission
Institut National Du Cancer
Agence Nationale de la Recherche
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference5 articles.
1. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors;Travis;Nat Rev Clin Oncol,2013
2. Assessing the risk of second malignancies after modern radiotherapy;Newhauser;Nat Rev Cancer,2011
3. Second cancers in survivors of childhood cancer;Bhatia;Nat Rev Cancer,2002
4. The ConSoRe project supports the implementation of big data in oncology;Heudel;Bull Cancer,2016
5. Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis;Xu;BMJ,2018
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic Therapy;Current Oncology Reports;2024-05-23
2. From data strategy to implementation to advance cancer research and cancer care: A French comprehensive cancer center experience;PLOS Digital Health;2023-12-19
3. Does perioperative immunotherapy reduce the risk of second primary cancers?;European Journal of Cancer;2023-11
4. Radiation-Associated Angiosarcoma as a Presentation of Disease Progression in a Patient on Immunotherapy for Metastatic Non-small Cell Lung Cancer;Cureus;2023-09-05
5. Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors;Lung Cancer;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3